Show simple item record

dc.contributor.authorAbdelsalam Elshenawy, Rasha
dc.contributor.authorUmaru, Nikkie
dc.contributor.authorAslanpour, Zoe
dc.date.accessioned2024-11-12T08:45:01Z
dc.date.available2024-11-12T08:45:01Z
dc.date.issued2024-11-11
dc.identifier.citationAbdelsalam Elshenawy , R , Umaru , N & Aslanpour , Z 2024 , ' Trends in Antibiotic Use in a UK Secondary Care Prior to and During the COVID-19 Pandemic: A Cross-Sectional Retrospective Study (poster) ' , Royal pharmaceutical society annual conference 2024 , London , United Kingdom , 8/11/24 - 8/11/24 . < https://www.research.herts.ac.uk/admin/files/66060554/RPS_Poster_-_108-2024-RA_1_.pdf >
dc.identifier.citationconference
dc.identifier.otherORCID: /0000-0002-2567-0540/work/171844968
dc.identifier.otherORCID: /0000-0002-8954-0817/work/171844998
dc.identifier.urihttp://hdl.handle.net/2299/28446
dc.description.abstractThis study evaluates antibiotic usage trends in a UK secondary care setting, comparing pre-pandemic (2019) and pandemic (2020) data. The focus is on antibiotic use among adults admitted for respiratory tract infections (RTIs) and pneumonia, assessed using the WHO AWaRe classification and Defined Daily Dose (DDD). Findings reveal a notable increase in "Watch" category antibiotics, particularly azithromycin, clarithromycin, and levofloxacin, reflecting shifts in prescribing practices likely driven by COVID-19. These increases underscore the need for enhanced antimicrobial stewardship to prevent exacerbation of AMR. The study highlights the importance of careful antibiotic management to ensure patient safety and combat AMR.en
dc.format.extent635385
dc.language.isoeng
dc.subjectAntimicrobial resistance (AMR)
dc.subjectAntibiotic Use
dc.subjectCOVID-19 pandemic
dc.subjectAntimicrobial stewardship (AMS)
dc.subjectSecondary care
dc.subjectDefined Daily Dose (DDD)
dc.subjectWHO AWaRe classification
dc.subjectRespiratory tract infections (RTIs)
dc.subjectPrescribing trends
dc.subjectLevofloxacin
dc.subjectAntibiotic prescribing trends
dc.subjectMacrolide
dc.subjectMacrolides/pharmacology
dc.subjectantibiotic classification
dc.subjectAntibiotic guardian
dc.subjectAntibiotic Guidelines
dc.subjectAntibiotic Prescribing
dc.subjectAntibiotic research
dc.subjectAntibiotic resistance
dc.subjectAntibiotic Safety Measures
dc.subjectAntibiotic Stewardship
dc.subjectWHO guidelines
dc.titleTrends in Antibiotic Use in a UK Secondary Care Prior to and During the COVID-19 Pandemic: A Cross-Sectional Retrospective Study (poster)en
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionCentre for Future Societies Research
dc.description.statusPeer reviewed
dc.date.embargoedUntil2024-11-08
dc.identifier.urlhttps://www.research.herts.ac.uk/admin/files/66060554/RPS_Poster_-_108-2024-RA_1_.pdf
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record